Trending Now
Aptevo Therapeutics Inc. (NASDAQ:APVO) Reports Patient Remission In The APVO436 Phase...
Aptevo Therapeutics Inc. (NASDAQ:APVO) has offered an update on the ongoing APVO436 Phase clinical trials in which the company reported the first complete remission...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Receive Approval From European Commission For Expanded...
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has announced that it has received approval from the EU for KALYDECO® granules label extension. The extension includes treatment of...
MAKE IT MODERN
LATEST REVIEWS
Palisade Bio Inc (NASDAQ: PALI) Commences Dosing Of Patients In Phase...
Palisade Bio Inc (NASDAQ: PALI) has announced the dosing of the first patient in the third phase LB1148 assessment to accelerate bowel function restoration...
MAKE IT MODERN
PERFORMANCE TRAINING
ChargePoint Holdings Inc (NYSE:CHPT) unusual options activity indicates increased interest
CPI number that we see this morning is going to make an impact in the market one way or another. Stocks have...
Omeros Corporation (NASDAQ:OMER) Reports Successful Treatment Of Six COVID-19 Patients With ARDS Using Narsoplimab
Omeros Corporation (NASDAQ:OMER) reported the outcome of a compassionate trial investigating narsoplimab. It treated all six coronavirus patients with ARDS (Acute Respiratory Distress Syndrome)....
Investors Focus on Top Metaverse Plays as New Year Gets in Gear (U, EPAZ,...
The investing landscape for 2022 is uncertain, as we have seen over recent days. The year has started with selling driven by...
Pfizer’s (NYSE: PFE) Ponsegromab Shows Promise in Fighting Cancer Cachexia
Pfizer (NYSE: PFE) recently announced positive results from a midstage trial of their experimental drug, ponsegromab, designed to treat cancer cachexia, a...
The FDA Agrees With Aldeyra Therapeutics Inc. (NASDAQ:ALDX) On RASP Inhibitor In Dry Eye...
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) has announced that it has reached an agreement with the FDA regarding the uses of reactive aldehyde species (RASP) as...
MAKE IT MODERN
